Positron Corporation out of Fishers, Indiana will be unveiling next week its new system for automatic preparation of radiomarkers used in diagnostic imaging. The company will be showing off the PosiRx device, which mainly deals with technetium 99m SPECT imaging agents, at the American Pharmacists Association Annual Meeting and Exposition in Seattle.
The PosiRx system has simplified the steps involved in dose preparation and delivery by automating many of the compounding processes including generator elution, kit compounding, unit dose preparation and generator QC. This automation allows PosiRx to minimize the possibility of an operator introducing contaminants into the compliant environment and ensures consistency in each step of the dose delivery process. PosiRx is a self-contained system that provides immediate availability of a radiopharmaceutical supply around the clock.
The PosiRx system allows the operator to manage every aspect of the compounding and dose drawing process with high levels of accuracy and reproducibility. Procedures are executed through an intuitive user interface with a few touchscreen inputs. The simplicity of its operation reduces the need for extensive training, resulting in improved output and a reallocation of resources.
PosiRx also creates an ISO Class 5 environment that is essential for allowing users to prepare and handle radiopharmaceuticals. During the development of this system, engineers implemented the principles of ALARA into its design by strategically shielding the user and reducing the time spent in proximity to the radioactive source. By combining automation and shielding, technologists are exposed to little or no radiation during the compounding process. Additionally, PosiRx reduces the number and complexity of protocols necessary for compliance with current USP-797 requirements.
Press release: Positron to Launch Automated Radiopharmaceutical System…
Product page: PosiRx…
